Leerink Healthcare Services and Technology Team
Trending Content - Investment Banking Forum
| +215 | Downfall of Qatalyst | 41 | 6h |
| +167 | UBS IB 26Q2 a Disaster! Advisory Revenue Down 23%, Capital MarketsDown 5% | 22 | 2d |
| +109 | UBS Americas IB: The Kids’ Table of Wall Street | 15 | 2h |
| +81 | Lincoln International Return Offers | 42 | 1d |
| +52 | so confused about 28 SA timeline | 27 | 5d |
| +44 | London IB BB is a challenge | 29 | 2h |
| +37 | momentum of Rx groups | 11 | 1d |
| +36 | Fired during interview | 6 | 6h |
| +33 | [WSO MODS] Please Delete This BS Host Books Spam! | 2 | 5d |
| +24 | VP Lifestyle at Top BB Coverage Groups | 10 | 53m |
Career Resources
SVB Leerink has been actively involved in significant transactions, particularly in the healthcare sector. They advised on the $3.3 billion sale of Dicerna to Novo Nordisk, showcasing their capability in handling large-scale deals in the healthcare industry. Additionally, their recent expansion into technology, with the advising on the $5.4 billion sale of Quest Software to Clearlake Capital, indicates a growing competence in tech-related financial services as well.
Regarding the healthcare services practices specifically at Leerink, while the context does not provide details about closed deals on their website or the return rate for past summers, the lateral moves of analysts to prestigious firms like Moelis M&A, MS M&A, and Jefferies HC suggest that Leerink is considered a solid group to join. These transitions imply that the experience and exposure gained at Leerink are valuable and recognized within the industry, making it a potentially good career move.
Sources: Is SVB Leerink Becoming an EB?, Is Leerink Turning Into EB?, Jefferies SA 2023, Credit Suisse, Barclays, and Jefferies Healthcare, Is Leerink Turning Into EB?
bump - curious as well
I mean all the banks that you listed out are significant level ups so makes sense.
Not sure what time period those laterals occurred, but it had deal flow up until last year when there was an exodus of senior bankers. I cannot imagine you will get good reps at anything outside of Biopharma at Leerink any longer.
Those laterals occured in recent 6 months
How long were they at SVB? They probably got a few deals done if they had been there for at least a year or longer.
Yes that makes sense - some of them joined at summer 2022 so probly had some experiences, but two guys who joined at summer 23 and lateraled to Moelis M&A and HL hc within a year and I don't know how they did it
Aliquam asperiores labore pariatur odit quod labore ab. Debitis ut itaque sit aut fuga tempora qui. Aut aut voluptas quo qui illum doloribus. Enim perspiciatis et et amet. Hic deserunt qui nam maxime. Quis ut reiciendis at qui.
Rerum a ut deserunt non sed. Saepe sunt velit voluptatem ea.
Odio et sunt consequuntur dolore quos at. Porro molestiae modi doloribus tempore.
Beatae illum magni iste modi. Ut qui autem quod libero quibusdam reiciendis. Quae aliquid fuga labore impedit. Quisquam sequi debitis architecto recusandae. Commodi molestiae nesciunt expedita tempore. Voluptatem quasi laborum nemo sed id exercitationem enim minus.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...